These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16369969

  • 1. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
    Magagnoli M, Masci G, Castagna L, Pedicini V, Poretti D, Morenghi E, Brambilla G, Santoro A.
    Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
    [Abstract] [Full Text] [Related]

  • 2. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.
    Magagnoli M, Masci G, Castagna L, Zucali PA, Morenghi E, Pedicini V, Santoro A.
    Anticancer Res; 2005 Jan; 25(4):3143-7. PubMed ID: 16080578
    [Abstract] [Full Text] [Related]

  • 3. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis.
    Heaton DC, Han DY, Inder A.
    Intern Med J; 2002 Mar; 32(3):84-8. PubMed ID: 11885848
    [Abstract] [Full Text] [Related]

  • 4. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A, Iannucci A, Dager WE.
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [Abstract] [Full Text] [Related]

  • 5. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis.
    Rawson KM, Newburn-Cook CV.
    Oncol Nurs Forum; 2007 Sep; 34(5):1037-43. PubMed ID: 17878131
    [Abstract] [Full Text] [Related]

  • 6. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P, Mille D, Laporte S, Charlet V, Buchmüller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H, CIP Study Group.
    Haematologica; 2003 Jan; 88(1):67-73. PubMed ID: 12551829
    [Abstract] [Full Text] [Related]

  • 7. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
    Verso M, Agnelli G.
    J Clin Oncol; 2003 Oct 01; 21(19):3665-75. PubMed ID: 14512399
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis.
    Ikhlaque N, Seshadri V, Kathula S, Baumann MA.
    Am J Hematol; 2006 Jun 01; 81(6):420-2. PubMed ID: 16680743
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
    Ergene U, Cağirgan S, Pehlivan M, Yilmaz M, Tombuloğlu M.
    Transfus Apher Sci; 2007 Feb 01; 36(1):23-9. PubMed ID: 17292672
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapy Insight: venous-catheter-related thrombosis in cancer patients.
    Agnelli G, Verso M.
    Nat Clin Pract Oncol; 2006 Apr 01; 3(4):214-22. PubMed ID: 16596145
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism.
    Monkman K, Lazo-Langner A, Kovacs MJ.
    Thromb Res; 2009 Jul 01; 124(3):275-80. PubMed ID: 19155056
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
    Haas PS, Bauchmüller K, Kühnemund A, Finke J, Ihorst G, Engelhardt M.
    Ann Hematol; 2006 Mar 01; 85(3):191-3. PubMed ID: 16365747
    [No Abstract] [Full Text] [Related]

  • 15. [Central venous totally implantable access for high dose chemotherapy in children].
    Conter C, Carausu L, Martin E, Rubie H, Castex MP, Marec-Berard P.
    Arch Pediatr; 2006 Mar 01; 13(3):256-61. PubMed ID: 16469486
    [Abstract] [Full Text] [Related]

  • 16. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.
    Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F.
    Acta Paediatr; 2006 Sep 01; 95(9):1053-9. PubMed ID: 16938749
    [Abstract] [Full Text] [Related]

  • 17. Thrombosis prophylaxis in cancer patients with a central venous catheter.
    Laporte S, Decousus H, Mismetti P.
    Arch Intern Med; 2004 Feb 23; 164(4):459; author reply 459-60. PubMed ID: 14980999
    [No Abstract] [Full Text] [Related]

  • 18. Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2.
    Eastman ME, Khorsand M, Maki DG, Williams EC, Kim K, Sondel PM, Schiller JH, Albertini MR.
    Cancer; 2001 Feb 15; 91(4):806-14. PubMed ID: 11241250
    [Abstract] [Full Text] [Related]

  • 19. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?
    Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B, Pedicini V, Fallini M, Santoro A.
    J Clin Oncol; 2003 Feb 15; 21(4):736-9. PubMed ID: 12586814
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.